Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 80Prostatic Neoplasms 57Carcinoma, Non-Small-Cell Lung 54Breast Neoplasms 54Esophageal Neoplasms 48Rectal Neoplasms 42Lung Neoplasms 42Brain Neoplasms 34Squamous Cell Carcinoma of Head and Neck 33Head and Neck Neoplasms 33Gliosarcoma 31Pancreatic Neoplasms 29Uterine Cervical Neoplasms 28Neoplasms 25Glioma 24Neoplasm Metastasis 23Sarcoma 22Oropharyngeal Neoplasms 21Esophageal Squamous Cell Carcinoma 20Melanoma 19Astrocytoma 18Adenocarcinoma Of Esophagus 15Stomach Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Squamous Cell 12Urinary Bladder Neoplasms 11Mouth Neoplasms 11Lymphoma, Follicular 11Central Nervous System Neoplasms 11Carcinoma 11

Interventions

durvalumab 2Radiotherapy 2Etoposide 2Drug Therapy 2Cisplatin 2trilaciclib 1tislelizumab 1pamiparib 1anlotinib 1Tirapazamine 1Surgical Procedures, Operative 1Sodium Chloride 1Radiation Dose Hypofractionation 1Radiation 1Probiotics 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Glucose 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Radiation × Clear all
NCT00066742 2014-05-15

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled 8 charts
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡